Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthma

Respiratory Medicine

Volumn 92, Issue 12, 1998, Pages 1359-1363

  Harrison, T W ^a   Tattersfield, A E ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; LOCAL ANESTHETIC AGENT; METHACHOLINE; SALBUTAMOL; STEROID;

ADULT; ARTICLE; ASTHMA; BLOOD PRESSURE; BRONCHOSPASM; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0032425316     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90142-1     Document Type: Article

References (14)

1. Hill JM, Tattersfield AE. Corticosteroid sparing agents in asthma. Thorax 1995; 50: 577-582.
2. Hunt LW, Swedlund HA, Gleich GJ. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma. Mayo Clin Proc 1996; 71: 361-368.
3. Miller WC, Awe R. Effect of nebulized lidocaine on reactive airways. Am Rev Respir Dis 1975; 111: 739-741.
4. Weiss EB, Patwarhan AV. Lidocaine in bronchial asthma. Chest 1977; 72: 429-438.
5. Fish JE, Peterman VI. Effects of inhaled lidocaine on airway function in asthmatic subjects. Respiration 1979; 37: 201-207.
6. McAlpine LG, Thomson NC. Lidocaine-induced bronchoconstriction in asthmatic patients. Relation to histamine airway responsiveness and effect of preservative. Chest 1989; 96: 1012-1015.
7. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 760-765.
8. Fanta CH, Ingram RH, McFadden ER. A reassessment of the effects of oropharyngeal anaesthesia in exercise-induced asthma. Am Rev Respir Dis 1980; 122: 381-386.
9. Prakash GS, Sharma SK, Pande JN. Effect of 4% lidocaine inhalation in bronchial asthma. J Asthma 1990; 27: 81-85.
10. Groeben H, Foster WM, Brown RH. Intravenous lidocaine and oral mexilitine block reflex bronchocon-striction in asthmatic subjects. Am J Respir Crit Care Med 1996; 154: 885-888.
11. Groeben H, Schwalen A, Irsfeld S, Stieglitz S, Lipfert P, Hopf H-B. Intravenous lidocaine and bupivicaine dose-dependently attenuate bronchial hyperreactivity in awake volunteers. Anesthesiology 1996; 84: 533-539.
12. Caire N, Cartier A, Ghezzo H, L'Archevêque J, Malo J-L. Inhaled lignocaine does not alter bronchial hyperresponsiveness to hyperventilation of dry cold air in asthmatic subjects. Clin Exper Allergy 1989; 19: 65-70.
13. Wilcock A, Corcoran R, Tattersfield AE. Safety and efficacy of nebulised lignocaine in patients with cancer and breathlessness. Palliative Med 1994; 8: 35-38.
14. Blair MR. Cardiovascular pharmacology of local anaesthetics. Br J Anaesth 1975; 47: 427-252.